Veriheal

DECEMBER 9, 2021

When cannabis legalization began to gain ground and support, those who remained opposed to these policy changes touted claims that legalization would increase the risk of mental illness or even suicide among affected populations. We found that recreational marijuana access was associated with a 6.29 Support From Other Studies.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MMJ Recs

MARCH 23, 2024

Health Effects of Cannabis Legalization in Michigan The health effects of cannabis legalization in Michigan encompass both potential benefits and risks for residents. Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief.

Legalization 52

Legalization Access Programs Education 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. The cannabis research problem. Despite the massive amount of research publications that come out year over year, many of these studies face one or more research design limitations.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

FEBRUARY 5, 2022

Senior Associate, David Hardstaff and Partner, John Binns of BCL Solicitors LLP , explore the UK’s doomed Medical Cannabis (Access) Bill. For UK-based patients struggling to access much needed cannabis-based medicines, it has been difficult to be heard over the white noise of the daily news cycle. Barriers to patient access.

Access 52

Access Research and Development Medicine Patients 52

Cannabis Law Report

APRIL 28, 2022

Get a bunch of researchers to research it, publish a report for committees to mull over and then ignore. The researchers leading the study were all affiliated with The University of Queensland , and they examined, “historical changes in legalization attitudes and the period-specific individual and external influences on these.”. “A

Legalization 52

Legalization Research and Development Media Data 52

MMJ Recs

FEBRUARY 27, 2024

As the state continues to navigate the complexities of legalization, patients, dispensaries, and the cannabis industry are witnessing significant changes. Dispensaries serve as the primary access point for patients seeking medical marijuana products. Medications, physical therapy, and, in some cases, surgery may be recommended.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

NewsMunchies

JULY 10, 2023

Artificial intelligence is a smarter, faster, and more effective pathway to drug development. With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

Veriheal

NOVEMBER 30, 2021

Veriheal does not support illegally consuming therapeutic substances such as psilocybin but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Research and Development 98

Research and Development Therapy Data Treatment 98

Cannabis Law Report

MAY 29, 2022

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms. A new cultivation facility that is hoping to change lives with psychedelic mushrooms had their grand opening on Friday in Princeton, after being awarded a dealer’s license in February by Health Canada.

Research and Development 52

Research and Development Clinical Trials Medicine Access 52

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

The Cannigma

JUNE 19, 2022

Recreational cannabis is not legal in Colombia, but personal consumption and possession of the plant is decriminalized. Adult-use cannabis is not legal, but in 2012, the Colombian government decriminalized personal use of cannabis and possession of up to 20 grams. The country has had a medical cannabis program since 2015.

Legalization 97

Legalization Decriminalization Research and Development Consumption 97

Cannabis Law Report

NOVEMBER 1, 2021

In the past few decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and 60s. Date Written: October 23, 2021. war on drugs.

Research and Development 52

Research and Development Law Clinical Trials Therapy 52

Veriheal

MARCH 17, 2022

However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” New Research Published on Serotonergic Psychedelic Use and Psychosis. New Research Published on Serotonergic Psychedelic Use and Psychosis. The research team under the leadership of Alexander V.

Research and Development 98

Research and Development Therapy Conditions History 98

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

CannaMD

MARCH 24, 2021

As marijuana legalization continues to expand across the country, scientists are interested in tracking how legalization influences adolescents. Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis.

Treatment 104

Treatment Legalization Marijuana Research and Development 104

Veriheal

AUGUST 24, 2022

Colorado could legalize psychedelics. These include legalizing the possession, cultivation, use, and sharing of psychedelic components such as ibogaine , mescaline , DMT, psilocybin , and psilocin for adults over the age of 21. The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

MMJ Recs

MARCH 16, 2024

Overview of the Medical Marijuana Industry The medical marijuana industry has experienced significant growth and evolution in recent years, fueled by shifting attitudes, changing regulations, and expanding legalization efforts across various jurisdictions.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

AUGUST 20, 2022

CRCC’s paper, published by the Ohio State University (OSU) Moritz College of Law, is titled “Not a SAFE Bet: Equitable Access to Cannabis Banking, An Analysis of the SAFE Banking Act.”. Ohio State Legal Studies Research Paper No. Ohio State Legal Studies Research Paper No. 21 Pages Posted: 12 Aug 2022. Cat Packer.

Banking 52

Banking Access Research and Development Policy 52

MMJ Recs

FEBRUARY 10, 2024

This article explores the history of medical marijuana in Ohio, analyzes the changing attitudes and acceptance, and delves into the impact of stigma on its journey to legalization. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.

Research and Development 105

Research and Development Marijuana History Legislation 105

Veriheal

MARCH 6, 2024

Let’s make one thing clear, rescheduling cannabis does not mean that it is suddenly federally legal. The other big change that comes with rescheduling is an increase in cannabis research opportunities. As Oregon-based research firm Whitney Economics highlighted, in 2022 state-legal cannabis businesses paid more than $1.8

Research and Development 62

Research and Development DEA Chronic Pain Business 62

Cannabis Law Report

APRIL 13, 2022

Delic Labs’ latest exemptions enable the Company to develop innovative analytical methods for psychedelic research. Last year, the lab also applied for a Dealer’s License with the intent of commercializing psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

Cannabis Law Report

JULY 8, 2021

The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We We are grateful for this grant, and especially for the opportunity to further our research in this space,’ says Professor Downey. ‘It Medicinal Cannabis Research Collaboration (MCRC).

Medicine 98

Medicine Research and Development Safety THC 98

Canna Law Blog

SEPTEMBER 30, 2020

In recent posts, we’ve explored legislative developments regarding cannabis in Argentina , Colombia and Mexico. Today, we turn our attention to Central America, and specifically Costa Rica, where a bill that seeks to legalize medical cannabis is winding its way through the legislative process.

Legalization 97

Legalization Research and Development Agriculture Hemp 97

Cannabis Law Report

DECEMBER 9, 2021

Nue Life is donating $50,000 to MAPS and $10,000 to the Ketamine Research Foundation. “We believe it is the responsibility of psychedelic-therapy companies to provide material support to the life-changing research being done in the space, which has made our work possible. . MIAMI , Dec. ” About Nue Life.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

WeedAdvisor

FEBRUARY 20, 2019

Banks Pushing for Access to Legal Marijuana Industry. In yet another unprecedented leap forward, United States banks are asking Congress to protect them from federal prosecution over dealing with legal marijuana businesses, according to U.S. Banks Pushing for Access to Legal Marijuana Industry appeared first on WeedAdvisor.

Banking 40

Banking Access Legalization Marijuana 40

Veriheal

FEBRUARY 18, 2021

But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy.

Therapy 52

Therapy Research and Development Collective Consumption 52

Cannabis Law Report

JUNE 24, 2022

The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws. Marijuana Moment reports.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

Cannabis Law Report

JULY 25, 2022

Is Medical Marijuana Legal in Pennsylvania? Medical marijuana is legal in Pennsylvania, but only for those who possess a medical marijuana card. Is Cannabis Legal in Pennsylvania? Medical marijuana is legal in Pennsylvania but it can be accessed only by registered patients with a medical marijuana card.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Veriheal

AUGUST 11, 2023

Pennsylvania inches toward psychedelic legalization, cannabis delivery comes to New York, and RAW Rolling Papers makes a massive donation. The Conference was a strong showing of the growing movement to legalize psychedelics in the Keystone State. Let’s dive into this week’s canna-news.

Research and Development 52

Research and Development Advocacy Therapy Access 52

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. BRC) told The Cannigma this week.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

JANUARY 27, 2022

Legislators in New York and Washington state recently introduced bills to legalize psilocybin services. This blog post summarizes the legislation in both states and explains the differences and similarities in adult use versus medicinal models of psilocybin legalization. New York: the “Medicinal” Approach.

Legalization 52

Legalization Research and Development Legislation Treatment 52

Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

Cannabis Law Report

JULY 19, 2021

Governor Ralph Northam announced appointments to the three newly-created boards that oversee marijuana legalization in Virginia. On July 1, recreational marijuana became legal for adult use in Virginia. WTKR reports. Board members cannot have financial interests in the cannabis industry. For more information on the board, click here.

Legalization 105

Legalization Research and Development Safety Advocacy 105

Cannabis Law Report

AUGUST 22, 2021

By registering ST1, TT1, UUA1 and RD1, Thailand is making those cultivars legal — not for recreational use, however, which remains outlawed. The process is expected to be completed this month and the government suggested in June that the registry will promote cannabis research. “We

Research and Development 105

Research and Development Sativa Strains Access 105